ArticleScientific reports2026
Machine learning for scalable obstructive sleep apnea risk screening using digital phenotyping from wearable devices and clinical scales.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Obstructive sleep apnea (OSA) is common yet frequently underdiagnosed, partly because overnight polysomnography (PSG) is logistically burdensome and access to specialized testing is limited. We aimed to develop machine-learning models for OSA risk screening using multimodal digital phenotyping from consumer-grade wearable devices, smartphone-based assessments, and clinical scales. We enrolled 338 participants and collected data over four weeks. After preprocessing, 107 features were derived from wearable-derived physiological and activity measures, smartphone-based records, and questionnaire-based clinical risk profiles, and used to classify high- versus low-risk OSA groups defined by the Berlin Questionnaire. Across multiple model configurations, predictive performance was high, with the best-performing model achieving an AUC of up to 0.94 and an F1 score of 0.80 in the internal validation set. Consistently influential predictors included body mass index, Insomnia Severity Index score, Smartphone Overuse Screening Questionnaire score, resting heart rate, and heart rate recovery. These findings suggest that multimodal digital phenotyping from accessible consumer technologies may support scalable pre-screening for OSA risk in real-world settings. Further validation against PSG-confirmed OSA outcomes is needed.Trial Registration: Clinical Research Information Service (CRIS) KCT0009175 (Registration data: Feb-15-2024) ( https://cris.nih.go.kr/cris/search/detailSearch.do?search_lang=E&focus=reset_12&search_page=M&pageSize=10&page=undefined&seq=26133&status=5&seq_group=26133 ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.